A Pentavalent <i>Shigella flexneri</i> LPS-Based Vaccine Candidate Is Safe and Immunogenic in Animal Models
A multivalent vaccine is much needed to achieve protection against predominant <i>Shigella</i> serotypes. Recently, we demonstrated the clinical applicability and immunogenic potential of tri-acylated <i>S. flexneri</i> 2a lipopolysaccharide (Ac<sub>3</sub>-S-LPS)...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-02-01
|
| Series: | Vaccines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-393X/11/2/345 |